ARCT · NASDAQ · Biotechnology

Arcturus Therapeutics

Develops mRNA medicines for rare diseases and a CSL-partnered COVID-19 vaccine.

$15.10
After-hours close−0.09 (−0.59%)
At close$15.19(−6.06%)

Breakdown13F · Form 4

Institutions 88.72%25.22M sharesInsiders 0.79%224.0K sharesOther 10.49%2.98M shares

Shares outstanding 28.42M · Float 26.15M · 92.0% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Federated Hermes, Inc.3.30M11.62%13FAug 12, 2026
Ark Investment Management LLC2.90M10.21%13FAug 14, 2026
BlackRock, Inc.2.61M9.20%13FAug 7, 2026
Sumitomo Mitsui Trust Group, Inc.1.96M6.91%13FJul 30, 2026
Nikko Asset Management Americas, Inc.1.96M6.90%13FAug 13, 2026

Institutions13F, as of Jun 30, 2026

139 holders · 25.22M shares · 21 new positions · 76 increased · 40 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
Federated Hermes, Inc.3.30M11.62%0Aug 12, 2026
Ark Investment Management LLC2.90M10.21%+132.1KAug 14, 2026
BlackRock, Inc.2.61M9.20%+731Aug 7, 2026
Sumitomo Mitsui Trust Group, Inc.1.96M6.91%−325.8KJul 30, 2026
Nikko Asset Management Americas, Inc.1.96M6.90%−328.5KAug 13, 2026
Vanguard Capital Management LLC1.11M3.92%+7.9KAug 13, 2026
Two Sigma Investments, LP1.09M3.84%+9.4KAug 14, 2026
Vanguard Portfolio Management LLC951.6K3.35%−26.3KAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Federated Hermes, Inc.11.63%3.30M13GJan 8, 2026
ARK Investment Management LLC10.37%2.95M13GMay 7, 2026
Nikko Asset Management Co., Ltd. (“NAM”)incl. Sumitomo Mitsui Trust Group, Inc.  (“SMTG”)8.56%2.32M13GNov 5, 2024
BlackRock, Inc.7.80%2.10M13GApr 23, 2025
Amova Asset Management Americas, Inc.7.20%1.95M13GNov 13, 2025
Sumitomo Mitsui Trust Group, Inc.7.20%1.95M13GOct 27, 2025
Nikko Asset Management Americas, Inc.7.10%1.93M13GMay 12, 2025

InsidersForm 4

InsiderRoleShares% outstandingFiled
Andy Sassinedirector, officer: Chief Financial Officer221.8K0.78%Aug 20, 2025
Joseph Robertsofficer: Controller2.2K0.01%Dec 19, 2025

10 people have not refiled in the last 18 months (3.40M shares), so they are not in the figure above

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.